DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Chawla G, Chaudhary KK.
A complete review of empagliflozin: Most specific and potent SGLT-2 inhibitor used for the treatment of type 2 diabetes mellitus.
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019;
13: 2001-2008 . doi:10.1016/j.dsx.2019.04.035
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.